NYSE:RVTY • US7140461093
The current stock price of RVTY is 97.57 USD. In the past month the price decreased by -14.87%. In the past year, price decreased by -13%.
ChartMill assigns a fundamental rating of 5 / 10 to RVTY. There are concerns on the financial health of RVTY while its profitability can be described as average.
Over the last trailing twelve months RVTY reported a non-GAAP Earnings per Share(EPS) of 5.07. The EPS increased by 3.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.45% | ||
| ROA | 1.98% | ||
| ROE | 3.33% | ||
| Debt/Equity | 0.36 |
26 analysts have analysed RVTY and the average price target is 120.44 USD. This implies a price increase of 23.44% is expected in the next year compared to the current price of 97.57.
For the next year, analysts expect an EPS growth of 8.5% and a revenue growth 4.62% for RVTY
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.69 | 192.995B | ||
| DHR | DANAHER CORP | 24.67 | 148.11B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 143.62 | 47.72B | ||
| A | AGILENT TECHNOLOGIES INC | 18.7 | 35.276B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.85 | 28.054B | ||
| IQV | IQVIA HOLDINGS INC | 12.38 | 27.46B | ||
| WAT | WATERS CORP | 22.08 | 19.016B | ||
| ILMN | ILLUMINA INC | 23.54 | 18.622B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.58 | 17.832B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.06 | 12.341B |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
REVVITY INC
77 4Th Avenue
Waltham MASSACHUSETTS US
Employees: 11000
Phone: 17816636900
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
The current stock price of RVTY is 97.57 USD. The price decreased by -0.05% in the last trading session.
REVVITY INC (RVTY) has a dividend yield of 0.28%. The yearly dividend amount is currently 0.28.
RVTY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
REVVITY INC (RVTY) currently has 11000 employees.
REVVITY INC (RVTY) has a market capitalization of 11.06B USD. This makes RVTY a Large Cap stock.
The outstanding short interest for REVVITY INC (RVTY) is 6.25% of its float.